OncoPlex Diagnostics Overview
- Year Founded
-
2001

- Status
-
Acquired/Merged
- Employees
-
25

- Latest Deal Type
-
M&A
OncoPlex Diagnostics General Information
Description
Provider of clinical proteomics and genetic mutation for the treatment of cancer patient. The company provides proprietary technology to solubilize tumor cell proteins from FFPE tissue for quantitation by mass spectrometry analysis.
Contact Information
Website
www.oncoplexdx.comCorporate Office
- 9600 Medical Center Drive
- Suite 300
- Rockville, MD 20850
- United States
Corporate Office
- 9600 Medical Center Drive
- Suite 300
- Rockville, MD 20850
- United States
OncoPlex Diagnostics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 10-Sep-2015 | Completed | Generating Revenue | |||
1. Later Stage VC | 01-Jan-2008 | Completed | Generating Revenue |
OncoPlex Diagnostics Signals
OncoPlex Diagnostics Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
TEDCO | Venture Capital | Minority | ||
VentureCross Partners | Venture Capital | Minority |
OncoPlex Diagnostics FAQs
-
When was OncoPlex Diagnostics founded?
OncoPlex Diagnostics was founded in 2001.
-
Where is OncoPlex Diagnostics headquartered?
OncoPlex Diagnostics is headquartered in Rockville, MD.
-
What is the size of OncoPlex Diagnostics?
OncoPlex Diagnostics has 25 total employees.
-
What industry is OncoPlex Diagnostics in?
OncoPlex Diagnostics’s primary industry is Diagnostic Equipment.
-
Is OncoPlex Diagnostics a private or public company?
OncoPlex Diagnostics is a Private company.
-
What is OncoPlex Diagnostics’s current revenue?
The current revenue for OncoPlex Diagnostics is
. -
Who are OncoPlex Diagnostics’s investors?
TEDCO and VentureCross Partners have invested in OncoPlex Diagnostics.
-
When was OncoPlex Diagnostics acquired?
OncoPlex Diagnostics was acquired on 10-Sep-2015.
-
Who acquired OncoPlex Diagnostics?
OncoPlex Diagnostics was acquired by NantOmics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »